Mechanism of alternative splicing and its regulation (Review)

By  

Biomedical Reports, Vol. 3, Iss. 2, 2015-03 ,pp. : 152-158

Science Publishers

Access to resources Recommend Favorite

Alternative Splicing, DNA Damage and Modulating Drugs in Radiation Therapy for Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 6, 2015-01 ,pp. : 674-680

Bentham Science Publishers

Access to resources Recommend Favorite

Is there a genomic basis for primary chemoresistance in ovarian cancer?

By Annunziata C.M.   Kohn E.C.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Biomarker Conservation in Primary and Metastatic Epithelial Ovarian Cancer

By Tewari K.S.   Kyshtoobayeva A.S.   Mehta R.S.   Yu I.-R.   Burger R.A.   DiSaia P.J.   Fruehauf J.P.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 130-136

Elsevier

Access to resources Recommend Favorite

Mammalian Sulf1 RNA alternative splicing and its significance to tumour growth regulation

By Gill Rai  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1669-1680

Springer Publishing Company

Access to resources Recommend Favorite